S-allyl cysteine ameliorates cognitive deficits in streptozotocin-diabetic rats via suppression of oxidative stress, inflammation, and acetylcholinesterase

European Journal of Pharmacology

Volumn 794, Issue , 2017, Pages 69-76

  Baluchnejadmojarad, Tourandokht ^a   Kiasalari, Zahra ^b   Afshin Majd, Siamak ^b   Ghasemi, Zahra ^b   Roghani, Mehrdad ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Cognition; Diabetes mellitus; Learning and memory; S allyl cysteine; Streptozotocin

Indexed keywords

ACETYLCHOLINESTERASE; CATALASE; GLIBENCLAMIDE; GLUTATHIONE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; S ALLYLCYSTEINE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NRF2; BIOLOGICAL MARKER; CYSTEINE; S-ALLYLCYSTEINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; ENZYME ACTIVITY; FEMALE; INFLAMMATION; LEARNING DISORDER; LIPID PEROXIDATION; MEMORY CONSOLIDATION; MEMORY DISORDER; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE TEST; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; ANIMAL; AVOIDANCE BEHAVIOR; COGNITION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; HIPPOCAMPUS; MALE; MAZE TEST; METABOLISM; PATHOPHYSIOLOGY; PERCEPTIVE DISCRIMINATION; WISTAR RAT;

ACETYLCHOLINESTERASE; ANIMALS; AVOIDANCE LEARNING; BIOMARKERS; COGNITION; CYSTEINE; DIABETES MELLITUS, EXPERIMENTAL; DISCRIMINATION (PSYCHOLOGY); HIPPOCAMPUS; INFLAMMATION; LIPID PEROXIDATION; MALE; MAZE LEARNING; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84996607257     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2016.11.033     Document Type: Article

References (76)

1. Alam, J., Cook, J.L., Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr. Pharm. Des. 9 (2003), 2499–2511.
2. Alrefaie, Z., Alhayani, A., Vitamin D(3) improves decline in cognitive function and cholinergic transmission in prefrontal cortex of streptozotocin-induced diabetic rats. Behav. Brain Res. 287 (2015), 156–162.
3. Ashafaq, M., Khan, M.M., Shadab Raza, S., Ahmad, A., Khuwaja, G., Javed, H., Khan, A., Islam, F., Siddiqui, M.S., Safhi, M.M., Islam, F., S-allyl cysteine mitigates oxidative damage and improves neurologic deficit in a rat model of focal cerebral ischemia. Nutr. Res. 32 (2012), 133–143.
4. Bales, K.R., Du, Y., Dodel, R.C., Yan, G.M., Hamilton-Byrd, E., Paul, S.M., The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. Brain Res. Mol. Brain Res. 57 (1998), 63–72.
5. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976), 248–254.
6. Brands, A.M., Biessels, G.J., de Haan, E.H., Kappelle, L.J., Kessels, R.P., The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28 (2005), 726–735.
7. Chao, H.M., Chen, I.L., Liu, J.H., S-allyl L-cysteine protects the retina against kainate excitotoxicity in the rat. Am. J. Chin. Med. 42 (2014), 693–708.
8. Chen, G., Zhang, S., Shi, J., Ai, J., Qi, M., Hang, C., Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp. Neurol. 216 (2009), 398–406.
9. Choi, A.M., Alam, J., Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 15 (1996), 9–19.
10. Claiborne, A., Catalase activity. Greenwald, RA, (eds.) CRC Handbook of Methods for Oxygen Radical Research, 1985, CRC, Boca Raton, FL, 283–284.
11. Colin-Gonzalez, A.L., Ali, S.F., Tunez, I., Santamaria, A., On the antioxidant, neuroprotective and anti-inflammatory properties of S-allyl cysteine: an update. Neurochem. Int. 89 (2015), 83–91.
12. Crane, P.K., Walker, R., Larson, E.B., Glucose levels and risk of dementia. N. Engl. J. Med. 369 (2013), 1863–1864.
13. Datusalia, A.K., Sharma, S.S., NF-kappaB inhibition resolves cognitive deficits in experimental type 2 diabetes mellitus through CREB and Glutamate/GABA neurotransmitters pathway. Curr. Neurovasc. Res. 13 (2016), 22–32.
14. Di Marco, E., Jha, J.C., Sharma, A., Wilkinson-Berka, J.L., Jandeleit-Dahm, K.A., de Haan, J.B., Are reactive oxygen species still the basis for diabetic complications?. Clin. Sci. 129 (2015), 199–216.
15. Ding, B.J., Ma, W.W., He, L.L., Zhou, X., Yuan, L.H., Yu, H.L., Feng, J.F., Xiao, R., Soybean isoflavone alleviates beta-amyloid 1-42 induced inflammatory response to improve learning and memory ability by down regulation of Toll-like receptor 4 expression and nuclear factor-kappaB activity in rats. Int. J. Dev. Neurosci. 29 (2011), 537–542.
16. D'Souza, M., Kulkarni, V., Bhaskaran, U., Ahmed, H., Naimish, H., Prakash, A., S, T, Dahiya, B., Thapar, R., Mithra, P., Kumar, N., Holla, R., Bb, D., Kumar, A., Diabetic peripheral neuropathy and its determinants among patients attending a tertiary health care centre in Mangalore, India. J. Public Health Res., 4, 2015, 450.
17. Ellman, G.L., Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82 (1959), 70–77.
18. Ellman, G.L., Courtney, K.D., Andres, V. Jr., Feather-Stone, R.M., A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961), 88–95.
19. Erejuwa, O.O., Sulaiman, S.A., Wahab, M.S.A., Salam, S.K.N., Salleh, M.S.M., Gurtu, S., Comparison of antioxidant effects of honey, glibenclamide, metformin, and their combinations in the kidneys of streptozotocin-induced diabetic rats. Int. J. Mol. Sci. 12 (2011), 829–843.
20. Garcia, E., Santana-Martinez, R., Silva-Islas, C.A., Colin-Gonzalez, A.L., Galvan-Arzate, S., Heras, Y., Maldonado, P.D., Sotelo, J., Santamaria, A., S-allyl cysteine protects against MPTP-induced striatal and nigral oxidative neurotoxicity in mice: participation of Nrf2. Free Radic. Res. 48 (2014), 159–167.
21. Gokturk, H., Ulusu, N.N., Gok, M., Tuncay, E., Can, B., Turan, B., Long-term treatment with a beta-blocker timolol attenuates renal-damage in diabetic rats via enhancing kidney antioxidant-defense system. Mol. Cell. Biochem. 395 (2014), 177–186.
22. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M., Nabeshima, Y., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236 (1997), 313–322.
23. Javed, H., Khan, M.M., Khan, A., Vaibhav, K., Ahmad, A., Khuwaja, G., Ahmed, M.E., Raza, S.S., Ashafaq, M., Tabassum, R., Siddiqui, M.S., El-Agnaf, O.M., Safhi, M.M., Islam, F., S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res. 1389 (2011), 133–142.
24. Johnston, H., Boutin, H., Allan, S.M., Assessing the contribution of inflammation in models of Alzheimer's disease. Biochem. Soc. Trans. 39 (2011), 886–890.
25. Jolivalt, C.G., Hurford, R., Lee, C.A., Dumaop, W., Rockenstein, E., Masliah, E., Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp. Neurol. 223 (2010), 422–431.
26. Kalalian-Moghaddam, H., Baluchnejadmojarad, T., Roghani, M., Goshadrou, F., Ronaghi, A., Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats. Eur. J. Pharmacol. 698 (2013), 259–266.
27. Karkkainen, V., Pomeshchik, Y., Savchenko, E., Dhungana, H., Kurronen, A., Lehtonen, S., Naumenko, N., Tavi, P., Levonen, A.L., Yamamoto, M., Malm, T., Magga, J., Kanninen, K.M., Koistinaho, J., Nrf2 regulates neurogenesis and protects neural progenitor cells against Abeta toxicity. Stem Cells 32 (2014), 1904–1916.
28. Kawamoto, E.M., Cutler, R.G., Rothman, S.M., Mattson, M.P., Camandola, S., TLR4-dependent metabolic changes are associated with cognitive impairment in an animal model of type 1 diabetes. Biochem. Biophys. Res. Commun. 443 (2014), 731–737.
29. Kiasalari, Z., Roghani, M., Khalili, M., Rahmati, B., Baluchnejadmojarad, T., Antiepileptogenic effect of curcumin on kainate-induced model of temporal lobe epilepsy. Pharm. Biol. 51 (2013), 1572–1578.
30. Kimura, N., Diabetes mellitus induces alzheimer's disease pathology: Histopathological evidence from animal models. Int. J. Mol Sci., 2016, 17.
31. Li, C., Zhao, R., Gao, K., Wei, Z., Yin, M.Y., Lau, L.T., Chui, D., Yu, A.C., Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 8 (2011), 67–80.
32. Li, W., Kong, A.N., Molecular mechanisms of Nrf2-mediated antioxidant response. Mol. Carcinog. 48 (2009), 91–104.
33. Lima, M.M., Targa, A.D., Noseda, A.C., Rodrigues, L.S., Delattre, A.M., dos Santos, F.V., Fortes, M.H., Maturana, M.J., Ferraz, A.C., Does Parkinson's disease and type-2 diabetes mellitus present common pathophysiological mechanisms and treatments?. CNS Neurol. Disord. Drug Targets 13 (2014), 418–428.
34. Lin, C.C., Yin, M.C., Liu, W.H., Alleviative effects of s-allyl cysteine and s-ethyl cysteine on MCD diet-induced hepatotoxicity in mice. Food Chem. Toxicol. 46 (2008), 3401–3406.
35. Liu, Y., Liu, H., Yang, J., Liu, X., Lu, S., Wen, T., Xie, L., Wang, G., Increased amyloid beta-peptide (1-40) level in brain of streptozotocin-induced diabetic rats. Neuroscience 153 (2008), 796–802.
36. Ma, P., Mao, X.Y., Li, X.L., Ma, Y., Qiao, Y.D., Liu, Z.Q., Zhou, H.H., Cao, Y.G., Baicalin alleviates diabetesassociated cognitive deficits via modulation of mitogen-activated protein kinase signaling, brainderived neurotrophic factor and apoptosis. Mol. Med. Rep. 12 (2015), 6377–6383.
37. Maiese, K., Chong, Z.Z., Shang, Y.C., Mechanistic insights into diabetes mellitus and oxidative stress. Curr. Med. Chem. 14 (2007), 1729–1738.
38. Moghaddam, H.K., Baluchnejadmojarad, T., Roghani, M., Khaksari, M., Norouzi, P., Ahooie, M., Mahboobi, F., Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats. Mol. Neurobiol. 49 (2014), 820–826.
39. Mong, M.C., Yin, M.C., Nuclear factor kappaB-dependent anti-inflammatory effects of s-allyl cysteine and s-propyl cysteine in kidney of diabetic mice. J. Agric. Food Chem. 60 (2012), 3158–3165.
40. Motawi, T.K., Darwish, H.A., Hamed, M.A., El-Rigal, N.S., Naser, A.F., A therapeutic insight of niacin and coenzyme Q10 against diabetic encephalopathy in rats. Mol. Neurobiol., 2016.
41. Motohashi, H., Yamamoto, M., Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10 (2004), 549–557.
42. Nasri, S., Roghani, M., Baluchnejadmojarad, T., Rabani, T., Balvardi, M., Vascular mechanisms of cyanidin-3-glucoside response in streptozotocin-diabetic rats. Pathophysiology 18 (2011), 273–278.
43. Nasri, S., Roghani, M., Baluchnejadmojarad, T., Balvardi, M., Rabani, T., Chronic cyanidin-3-glucoside administration improves short-term spatial recognition memory but not passive avoidance learning and memory in streptozotocin-diabetic rats. Phytother. Res. 26 (2012), 1205–1210.
44. Navarrete, S., Alarcon, M., Palomo, I., Aqueous extract of tomato (Solanum lycopersicum L.) and ferulic acid reduce the expression of TNF-alpha and IL-1beta in LPS-activated macrophages. Molecules 20 (2015), 15319–15329.
45. Negi, G., Kumar, A., Sharma, S.S., Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-kappaB and Nrf2 cascades. J. Pineal Res. 50 (2011), 124–131.
46. Negi, G., Kumar, A., Joshi, R.P., Sharma, S.S., Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Biochem. Biophys. Res. Commun. 408 (2011), 1–5.
47. Oberg, F., Haseeb, A., Ahnfelt, M., Ponten, F., Westermark, B., El-Obeid, A., Herbal melanin activates TLR4/NF-kappaB signaling pathway. Phytomedicine 16 (2009), 477–484.
48. Ott, A., Stolk, R.P., van Harskamp, F., Pols, H.A., Hofman, A., Breteler, M.M., Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53 (1999), 1937–1942.
49. Park, J.M., Han, Y.M., Kangwan, N., Lee, S.Y., Jung, M.K., Kim, E.H., Hahm, K.B., S-allyl cysteine alleviates nonsteroidal anti-inflammatory drug-induced gastric mucosal damages by increasing cyclooxygenase-2 inhibition, heme oxygenase-1 induction, and histone deacetylation inhibition. J. Gastroenterol. Hepatol. 29:Suppl 4 (2014), 80–92.
50. Patel, S., Santani, D., Role of NF-kappa B in the pathogenesis of diabetes and its associated complications. Pharmacol. Rep. 61 (2009), 595–603.
51. Ray, B., Chauhan, N.B., Lahiri, D.K., The “aged garlic extract:” (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD). Curr. Med. Chem. 18 (2011), 3306–3313.
52. Roghani, M., Baluchnejadmojarad, T., Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vascul. Pharmacol. 51 (2009), 84–89.
53. Roghani, M., Joghataie, M.T., Jalali, M.R., Baluchnejadmojarad, T., Time course of changes in passive avoidance and Y-maze performance in male diabetic rats. Iran. Biomed. J. 10 (2006), 99–104.
54. Roghani, M., Joghataie, M.T., Jalili, M.R., Baluchnejadmojarad, T., Time Course of Changes in Passive Avoidance and Y-maze Performance in Male Diabetic Rats. Iran. Biom. J. 10 (2006), 99–104.
55. Ryan, C.M., van Duinkerken, E., Rosano, C., Neurocognitive consequences of diabetes. Am. Psychol. 71 (2016), 563–576.
56. Saravanan, G., Ponmurugan, P., Beneficial effect of S-allylcysteine (SAC) on blood glucose and pancreatic antioxidant system in streptozotocin diabetic rats. Plant Foods Hum. Nutr. 65 (2010), 374–378.
57. Saravanan, G., Ponmurugan, P., Ameliorative potential of S-allyl cysteine on oxidative stress in STZ induced diabetic rats. Chem. Biol. Interact. 189 (2011), 100–106.
58. Saravanan, G., Ponmurugan, P., Kumar, G.P.S., Rajarajan, T., Antidiabetic properties of S-allyl cysteine, a garlic component on streptozotocin-induced diabetes in rats. J. Appl. Biomed. 7 (2009), 151–159.
59. Saravanan, G., Ponmurugan, P., Senthil Kumar, G.P., Rajarajan, T., Antidiabetic effect of S-allylcysteine: Effect on plasma and tissue glycoproteins in experimental diabetes. Phytomedicine 17 (2010), 1086–1089.
60. Sedlak, J., Lindsay, R.H., Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25 (1968), 192–205.
61. Seto, S.W., Yang, G.Y., Kiat, H., Bensoussan, A., Kwan, Y.W., Chang, D., Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine. Int. J. Endocrinol., 2015, 2015, 810439.
62. Shaw, J.E., Sicree, R.A., Zimmet, P.Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87 (2010), 4–14.
63. Shi, H., Jing, X., Wei, X., Perez, R.G., Ren, M., Zhang, X., Lou, H., S-allyl cysteine activates the Nrf2-dependent antioxidant response and protects neurons against ischemic injury in vitro and in vivo. J. Neurochem. 133 (2015), 298–308.
64. Sima, A.A., Diabetes underlies common neurological disorders. Ann. Neurol. 56 (2004), 459–461.
65. Sohanaki, H., Baluchnejadmojarad, T., Nikbakht, F., Roghani, M., Pelargonidin improves passive avoidance task performance in a rat amyloid beta25-35 model of Alzheimer's disease via estrogen receptor independent pathways. Acta Med. Iran. 54 (2016), 245–250.
66. Song, F., Qi, X., Chen, W., Jia, W., Yao, P., Nussler, A.K., Sun, X., Liu, L., Effect of Momordica grosvenori on oxidative stress pathways in renal mitochondria of normal and alloxan-induced diabetic mice. Involvement of heme oxygenase-1. Eur. J. Nutr. 46 (2007), 61–69.
67. Stuart, S.A., Robertson, J.D., Marrion, N.V., Robinson, E.S., Chronic pravastatin but not atorvastatin treatment impairs cognitive function in two rodent models of learning and memory. PLoS One, 8, 2013, e75467.
68. Sun, J.S., Yang, Y.J., Zhang, Y.Z., Huang, W., Li, Z.S., Zhang, Y., Minocycline attenuates pain by inhibiting spinal microglia activation in diabetic rats. Mol. Med. Rep. 12 (2015), 2677–2682.
69. Syapin, P.J., Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. Br. J. Pharmacol. 155 (2008), 623–640.
70. Thakur, A.K., Rai, G., Chatterjee, S.S., Kumar, V., Beneficial effects of an Andrographis paniculata extract and andrographolide on cognitive functions in streptozotocin-induced diabetic rats. Pharm. Biol. 54 (2016), 1528–1538.
71. Tsai, S.J., Chiu, C.P., Yang, H.T., Yin, M.C., s-Allyl cysteine, s-ethyl cysteine, and s-propyl cysteine alleviate beta-amyloid, glycative, and oxidative injury in brain of mice treated by D-galactose. J. Agric. Food Chem. 59 (2011), 6319–6326.
72. Vomhof-Dekrey, E.E., Picklo, M.J. Sr., The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism. J. Nutr. Biochem. 23 (2012), 1201–1206.
73. Wang, J.Q., Yin, J., Song, Y.F., Zhang, L., Ren, Y.X., Wang, D.G., Gao, L.P., Jing, Y.H., Brain aging and AD-like pathology in streptozotocin-induced diabetic rats. J. Diabetes Res., 2014, 2014, 796840.
74. Yirmiya, R., Goshen, I., Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 25 (2011), 181–213.
75. Youn, H.S., Lim, H.J., Lee, H.J., Hwang, D., Yang, M., Jeon, R., Ryu, J.H., Garlic (Allium sativum) extract inhibits lipopolysaccharide-induced Toll-like receptor 4 dimerization. Biosci. Biotechnol. Biochem. 72 (2008), 368–375.
76. Zhang, X., Dong, H., Zhang, S., Lu, S., Sun, J., Qian, Y., Enhancement of LPS-induced microglial inflammation response via TLR4 under high glucose conditions. Cell. Physiol. Biochem. 35 (2015), 1571–1581.